CFTR and cystic fibrosis: However, here we show that the double combination of VX-770 and VX-445 is equally effective at rescuing G551D-CFTR channel function compared to the triple combination (Fig. 4F–G), indicating that the incorporation of VX-661 in treatment of CF caused by G551D-CFTR mutation may confer no additional benefit.